Supporting babies at high risk of cerebral palsy from the very beginning

Testing a family-centred early intervention program to improve outcomes for infants and support parents during the first critical months of life.

Supporting babies at high risk of cerebral palsy from the very beginning

July 1, 2026
Testing a family-centred early intervention program to improve outcomes for infants and support parents during the first critical months of life.
Read Transcript

The challenge

Cerebral palsy (CP) is the most common physical disability in childhood, affecting movement, posture and, for many children, speech, learning, feeding and other aspects of development. Every day in Australia, two babies are born with CP (Cerebral Palsy Alliance Research Institute, Sydney, 2023). While it is now possible to identify many infants at high risk within weeks of birth, access to evidence-based early intervention remains limited and inconsistent.

The first months of life are a critical period for brain development, when an infant's brain has its greatest capacity to adapt and learn. Supporting parents during this time is equally important, yet families of infants at high risk of CP often receive little structured support, despite mothers being more than 15 times more likely to experience depression than mothers of infants without CP.

A new approach to early intervention

Adjunct Associate Professor Cathy Morgan and Professor Nadia Badawi from Cerebral Palsy Alliance are evaluating the Very early Intensive Programme (VIP), a six-month intervention for babies identified as being at high risk of CP. Beginning when babies are between birth and four weeks’ corrected age, the program combines customised motor training and environmental enrichment with parent support and coaching.

The randomised controlled trial will involve 138 infants and compare the VIP with the standard parent education and monitoring that families currently receive. The study will assess whether the program improves infants' motor, cognitive and communication development, while also supporting parents' wellbeing, confidence and quality of life.

Early impact

The study is now underway, with recruitment across 10 neonatal intensive care units and special care nurseries in New South Wales. To date, 27 infants have been screened for eligibility, and 19 families have been enrolled in the trial. Although the study is still recruiting participants and analysis has yet to begin, many families have already shared positive feedback about their experience with the VIP intervention.

Parents have spoken about the value of the customised, family-centred approach and the confidence they have gained through personalised coaching and support during the first months of their baby's life. Several families have also reached out to the research team to express their appreciation for the program. 

Beyond the trial, a monthly peer support group, led by parents with lived experience of raising a child with CP, has been established to help families connect with others navigating similar experiences. Resources have also been developed to support health professionals in having early diagnostic conversations with families. Listen to the podcast below to learn more about why these early conversations matter.

What this could unlock

If successful, the VIP Study will provide important evidence to guide the delivery of early intervention for infants at high risk of CP. The research aims to inform future clinical practice and policy, helping ensure families receive evidence-based, family-centred support during the earliest stages of their child's development. Researchers also hope to expand the model for families living in regional and remote Australia, where access to specialist allied health services is often limited.

Funding support from Hearts & Minds. This content was last updated in July 2026. For further information, visit Cerebral Palsy Alliance.

The challenge

Cerebral palsy (CP) is the most common physical disability in childhood, affecting movement, posture and, for many children, speech, learning, feeding and other aspects of development. Every day in Australia, two babies are born with CP (Cerebral Palsy Alliance Research Institute, Sydney, 2023). While it is now possible to identify many infants at high risk within weeks of birth, access to evidence-based early intervention remains limited and inconsistent.

The first months of life are a critical period for brain development, when an infant's brain has its greatest capacity to adapt and learn. Supporting parents during this time is equally important, yet families of infants at high risk of CP often receive little structured support, despite mothers being more than 15 times more likely to experience depression than mothers of infants without CP.

A new approach to early intervention

Adjunct Associate Professor Cathy Morgan and Professor Nadia Badawi from Cerebral Palsy Alliance are evaluating the Very early Intensive Programme (VIP), a six-month intervention for babies identified as being at high risk of CP. Beginning when babies are between birth and four weeks’ corrected age, the program combines customised motor training and environmental enrichment with parent support and coaching.

The randomised controlled trial will involve 138 infants and compare the VIP with the standard parent education and monitoring that families currently receive. The study will assess whether the program improves infants' motor, cognitive and communication development, while also supporting parents' wellbeing, confidence and quality of life.

Early impact

The study is now underway, with recruitment across 10 neonatal intensive care units and special care nurseries in New South Wales. To date, 27 infants have been screened for eligibility, and 19 families have been enrolled in the trial. Although the study is still recruiting participants and analysis has yet to begin, many families have already shared positive feedback about their experience with the VIP intervention.

Parents have spoken about the value of the customised, family-centred approach and the confidence they have gained through personalised coaching and support during the first months of their baby's life. Several families have also reached out to the research team to express their appreciation for the program. 

Beyond the trial, a monthly peer support group, led by parents with lived experience of raising a child with CP, has been established to help families connect with others navigating similar experiences. Resources have also been developed to support health professionals in having early diagnostic conversations with families. Listen to the podcast below to learn more about why these early conversations matter.

What this could unlock

If successful, the VIP Study will provide important evidence to guide the delivery of early intervention for infants at high risk of CP. The research aims to inform future clinical practice and policy, helping ensure families receive evidence-based, family-centred support during the earliest stages of their child's development. Researchers also hope to expand the model for families living in regional and remote Australia, where access to specialist allied health services is often limited.

Funding support from Hearts & Minds. This content was last updated in July 2026. For further information, visit Cerebral Palsy Alliance.

Disclaimer: This material has been prepared by Hearts & Minds, published on July 1, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
July 1, 2026

Improving care for adults with motor neuron diseases

Building better care for adults living with Motor Neuron Disease and Spinal Muscular Atrophy.

Read More
July 1, 2026

Understanding fatigue in young people with Charcot-Marie-Tooth disease

Developing a tool to improve understanding, research and care.

Read More
Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).
July 1, 2026

Giving families living with rare diseases the answers they need

Supporting research to improve the diagnosis of rare genetic neuromuscular diseases and build the foundations for future treatments.

Read More
Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher
July 1, 2026

Understanding spinal cord injury recovery

The world's first molecular map of spinal cord injury across time and injury levels

Read More
Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium
July 1, 2026

Building the foundations for faster progress against brain cancer

Uniting researchers, clinicians and patients to accelerate research and improve patient care.

Read More
July 1, 2026

Accelerating CAR-T cell therapies for patients in need 

Bringing innovative cancer therapies closer to patients.

Read More
July 1, 2026

Making early cerebral palsy screening more accessible

Exploring new ways to identify babies at risk of cerebral palsy sooner and support better outcomes.

Read More
Picture: Professor Tracy Putoczki, Laboratory Head at WEHIPicture: Professor Tracy Putoczki, Laboratory Head at WEHIPicture: Professor Tracy Putoczki, Laboratory Head at WEHIPicture: Professor Tracy Putoczki, Laboratory Head at WEHI
July 1, 2026

Mapping the surface of pancreatic cancer cells

Identifying proteins on pancreatic cancer cells that could become new targets for developing future treatments.

Read More
Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI
July 1, 2026

Understanding how breast cancer begins

Tracking the earliest changes in BRCA mutation carriers to help prevent cancer before it starts.

Read More
July 1, 2026

A new path forward for women living with period and pelvic pain

Uncovering the biology driving debilitating symptoms

Read More
Picture: Professor Daniel MacArthurPicture: Professor Daniel MacArthurPicture: Professor Daniel MacArthurPicture: Professor Daniel MacArthur
July 1, 2026

Closing the gap in rare disease diagnosis for Australian families

Building better genomic tools and more representative data to help families receive answers sooner.

Read More
PICTURE: A/Prof Rebecca Nisbet and her teamPICTURE: A/Prof Rebecca Nisbet and her teamPICTURE: A/Prof Rebecca Nisbet and her teamPICTURE: A/Prof Rebecca Nisbet and her team
July 1, 2026

Developing a new mRNA vaccine for Alzheimer’s disease

Using innovative technology to explore new possibilities for treatment and prevention.

Read More
Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS. Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS. Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS. Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS.
July 1, 2026

Unlocking new approaches for Multiple Sclerosis

Understanding why the brain fails to repair itself and exploring new treatment possibilities.

Read More
July 1, 2026

Helping emergency doctors make faster decisions with AI

Using Australian-developed artificial intelligence to improve emergency care.

Read More
July 1, 2026

Protecting vulnerable children, when it matters most

How the Safer Kids Project is helping identify and protect children at risk in emergency care

Read More